CannabisNewsBreaks

MondaySep 27, 2021 12:55 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Completes First Step in European Expansion Plan

Flora Growth Corp. (NASDAQ: FLGC) recently closed a €2 million investment in Hoshi International Inc., a fully integrated cannabis company, and uniquely positioned to become the leading provider of cannabis and derivative products for the budding European market. With the investment, Flora is set to capitalize on Hoshi’s strong European presence as well as leverage its technical know-how and understanding of its European market to not only expand its reach but also obtain its European Union Good Manufacturing Practices (“EU-GMP”) certification. A recent article reads, “Flora hopes to capitalize on Hoshi’s understanding of and presence within the European market to…

Continue Reading

FridaySep 24, 2021 2:11 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Enhancing Performance of Antiviral Drugs, CBD

Lexaria Bioscience Corp. (NASDAQ: LEXX) is making significant progress in advancing its patented DehydraTECH(TM) drug delivery technology. Lexaria recently reviewed its successful 2021 antiviral drug program. “The company has progressed significantly in evidencing that DehydraTECH can sufficiently enhance the usable fraction of known antiviral drugs that reach the bloodstream to safely and more effectively do what they are designed to accomplish,” reads a recent article. In addition to the antiviral program, Lexaria is also focused on another applied R&D program — hypertension. On July 29, it released partial results from a human clinical study, HYPER-H21-1, evaluating DehydraTECH-processed cannabidiol (“CBD”) for…

Continue Reading

FridaySep 24, 2021 1:56 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Continuing Momentum to Grow Sales, Revenue

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) is a pioneer in cannabis and hemp-derived product lines, strategically positioning itself to be among the top three multistate operators of these products within the American market. In late July of this year, the company released its Q1 2021 financial results in what Brand Rogers, RWB Chairman and CEO, described as “another great quarter for the company.” A recent article reads, “When making the announcement, Mr. Rogers also noted that the company would be building on the momentum from Q1, given how much traction it had received for its brand. More…

Continue Reading

FridaySep 24, 2021 1:05 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Release FY 2021 Financial Report and Corporate Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has released its financial results and corporate update for FY 2021. In addition, the company announced a conference call and webcast, in which company leadership will discuss the report. Interested parties can access a replay of the webcast for 90 days. Corporate highlights of the report include the definitive agreement the company entered to acquire BayMedica Inc., a private company specializing in the manufacture and commercialization of rare cannabinoids; the announcement that INM’s IntegraSyn(TM) cannabinoid manufacturing approach had achieved a level of 2g/L cannabinoid yield,…

Continue Reading

ThursdaySep 23, 2021 1:30 pm

CannabisNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Unveils New A88CBD(TM) Functional Waters

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company, has launched a new line of A88CBD(TM) functional waters powered by Vessl(R). The new natural CBD functional waters have six options: Relax, Refresh, Rest, Reenergize, Relief and Resistance. The new offerings feature the patented Vessl closure technology, which is designed to provide fresher ingredients and flavor. The new brand, which represents a strategic move into the functional beverages space for WTER, will be sold under the company’s A88 Infused Products Division Inc. With the Vessl closure technology, the CBD and other active, functional ingredients are stored in a…

Continue Reading

WednesdaySep 22, 2021 2:29 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) to Present at Wall Street Reporter’s ‘Next Super Stock’ Livestream Conference

RYAH Group (CSE: RYAH) today announced that its Chief Executive Officer Gregory Wagner will be presenting at Wall Street Reporter's "Next Super Stock" livestream conference on Thursday, Sept. 23, 2021. The online event is expected to give the investment community and existing shareholders an opportunity to interact in real time with Wagner and learn about the company and its operations. Wagner’s presentation is scheduled to begin at 1:00 ET on the day of the conference, during which he will highlight RYAH’s experience and mission, and, time permitting, open the floor for questions. Interested parties should visit https://cnw.fm/UPQ3T to ensure access…

Continue Reading

TuesdaySep 21, 2021 2:15 pm

CannabisNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) to Unveil New Offerings at Natural Products Expo East 2021

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and The Clean Beverage Company(TM), today announced that its subsidiaries, Alklaine88(R) and A88 Infused(TM) Products Inc., will be presenting their waters at the Natural Products Expo East on Sept. 23-25, 2021, in Philadelphia, Pennsylvania. A88 Infused Products Inc. will be featuring its brand-new line of six A88CBD(TM) functional waters in the “Hot Products” section of the Expo. “We are excited to return to in-person shows where people can sample and enjoy our Deliciously Smooth(TM) waters. After months of hard work and development, we will unveil…

Continue Reading

MondaySep 20, 2021 2:13 pm

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Enters Definitive Agreement to Acquire Embark Health Inc.

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has announced its entry into a definitive agreement dated Sept. 19, 2021, to acquire Embark Health Inc. According to the update, Embark has extensive manufacturing and intellectual property (“IP”) assets related to high-end solventless cannabis extracts and is also equipped to produce a range of cannabis concentrates, liquid and powder beverage mixes, topicals and edible products. Embark is also positioned for further growth in the health and wellness industry as the majority owner of ProteinQuest, which applies Embark’s innovative and proprietary…

Continue Reading

FridaySep 17, 2021 3:11 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Leveraging IoT Devices, AI Analytics to Provide Innovative Plant-Based Treatments

RYAH Group (CSE: RYAH), a connected device and big data and technology company, recently released a report outlining cannabis treatment options to address symptoms and conditions associated with HIV and AIDS. The report is based on information compiled by the RYAH Data Ecosystem, which enabled patients to submit data outlining symptoms they addressed with the use of cannabis, in addition to detailing specific cannabis strains used to treat those conditions. A recent article reads, “The ground-breaking report is part of RYAH’s data-driven mission to provide innovative plant-based medical treatments that leverage the use of IoT (Internet of Things) dose-measuring devices…

Continue Reading

FridaySep 17, 2021 2:58 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Enables Rapid, Sustained Drop in Blood Pressure

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator of proprietary patented drug-delivery platform DehydraTECH(TM), recently released partial results from human clinical study HYPER-H21-1. The study evaluated DehydraTECH-processed cannabidiol (“CBD”) for potential application against hypertension/high blood pressure. “The partial results showed that blood pressure was reduced across both male and female volunteers; it was more pronounced with DehydraTECH-CBD in the study’s first 10 to 50 minutes. These results reinforced the pre-existing findings demonstrating that DehydraTECH delivers superior performance over generic CBD controls,” reads a recent article. Lexaria was also pleased that the subjects of this human clinical study tolerated the DehydraTECH-CBD,…

Continue Reading